These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 31848135)
1. Absence of p.R50X Tarrasó G; Real-Martinez A; Parés M; Romero-Cortadellas L; Puigros L; Moya L; de Luna N; Brull A; Martín MA; Arenas J; Lucia A; Andreu AL; Barquinero J; Vissing J; Krag TO; Pinós T Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31848135 [TBL] [Abstract][Full Text] [Related]
2. Cell models for McArdle disease and aminoglycoside-induced read-through of a premature termination codon. Birch KE; Quinlivan RM; Morris GE Neuromuscul Disord; 2013 Jan; 23(1):43-51. PubMed ID: 22818872 [TBL] [Abstract][Full Text] [Related]
3. Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease. Nogales-Gadea G; Pinós T; Lucia A; Arenas J; Camara Y; Brull A; de Luna N; Martín MA; Garcia-Arumí E; Martí R; Andreu AL Brain; 2012 Jul; 135(Pt 7):2048-57. PubMed ID: 22730558 [TBL] [Abstract][Full Text] [Related]
4. A novel PYGM mutation in a Korean patient with McArdle disease: the role of nonsense-mediated mRNA decay. Sohn EH; Kim HS; Lee AY; Fukuda T; Sugie H; Kim DS Neuromuscul Disord; 2008 Nov; 18(11):886-9. PubMed ID: 18667317 [TBL] [Abstract][Full Text] [Related]
5. Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay. Nogales-Gadea G; Rubio JC; Fernandez-Cadenas I; Garcia-Consuegra I; Lucia A; Cabello A; Garcia-Arumi E; Arenas J; Andreu AL; Martín MA Hum Mutat; 2008 Feb; 29(2):277-83. PubMed ID: 17994553 [TBL] [Abstract][Full Text] [Related]
6. A proposed molecular diagnostic flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patients. Rubio JC; Garcia-Consuegra I; Nogales-Gadea G; Blazquez A; Cabello A; Lucia A; Andreu AL; Arenas J; Martin MA Hum Mutat; 2007 Feb; 28(2):203-4. PubMed ID: 17221871 [TBL] [Abstract][Full Text] [Related]
7. [McArdle disease (gycogenosis type V): analysis of clinical, biological and genetic features of five French patients]. Delmont E; Sacconi S; Berge-Lefranc JL; Aquaron R; Butori C; Desnuelle C Rev Neurol (Paris); 2008 Nov; 164(11):912-6. PubMed ID: 18808785 [TBL] [Abstract][Full Text] [Related]
8. High-resolution melting facilitates mutation screening of PYGM in patients with McArdle disease. Duno M; Quinlivan R; Vissing J; Schwartz M Ann Hum Genet; 2009 May; 73(Pt 3):292-7. PubMed ID: 19472443 [TBL] [Abstract][Full Text] [Related]
9. McArdle Disease: Update of Reported Mutations and Polymorphisms in the PYGM Gene. Nogales-Gadea G; Brull A; Santalla A; Andreu AL; Arenas J; Martín MA; Lucia A; de Luna N; Pinós T Hum Mutat; 2015 Jul; 36(7):669-78. PubMed ID: 25914343 [TBL] [Abstract][Full Text] [Related]
10. Systemic AAV8-mediated delivery of a functional copy of muscle glycogen phosphorylase (Pygm) ameliorates disease in a murine model of McArdle disease. McNamara EL; Taylor RL; Clayton JS; Goullee H; Dilworth KL; Pinós T; Brull A; Alexander IE; Lisowski L; Ravenscroft G; Laing NG; Nowak KJ Hum Mol Genet; 2020 Jan; 29(1):20-30. PubMed ID: 31511858 [TBL] [Abstract][Full Text] [Related]
11. Novel mutations in patients with McArdle disease by analysis of skeletal muscle mRNA. García-Consuegra I; Rubio JC; Nogales-Gadea G; Bautista J; Jiménez S; Cabello A; Lucía A; Andreu AL; Arenas J; Martin MA J Med Genet; 2009 Mar; 46(3):198-202. PubMed ID: 19251976 [TBL] [Abstract][Full Text] [Related]
12. The effect of muscle glycogen phosphorylase (Pygm) knockdown on zebrafish morphology. Migocka-Patrzałek M; Lewicka A; Elias M; Daczewska M Int J Biochem Cell Biol; 2020 Jan; 118():105658. PubMed ID: 31747538 [TBL] [Abstract][Full Text] [Related]
13. PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease? de Luna N; Brull A; Lucia A; Santalla A; Garatachea N; Martí R; Andreu AL; Pinós T Neuromuscul Disord; 2014 Dec; 24(12):1079-86. PubMed ID: 25240406 [TBL] [Abstract][Full Text] [Related]
15. Generation of the First Human In Vitro Model for McArdle Disease Based on iPSC Technology. Ortuño-Costela MDC; Cerrada V; Moreno-Izquierdo A; García-Consuegra I; Laberthonnière C; Delourme M; Garesse R; Arenas J; Fuster García C; García García G; Millán JM; Magdinier F; Gallardo ME Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430443 [TBL] [Abstract][Full Text] [Related]
16. Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model. Brull A; de Luna N; Blanco-Grau A; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T J Physiol; 2015 Jun; 593(12):2693-706. PubMed ID: 25873271 [TBL] [Abstract][Full Text] [Related]
17. McArdle disease: the mutation spectrum of PYGM in a large Italian cohort. Bruno C; Cassandrini D; Martinuzzi A; Toscano A; Moggio M; Morandi L; Servidei S; Mongini T; Angelini C; Musumeci O; Comi GP; Lamperti C; Filosto M; Zara F; Minetti C Hum Mutat; 2006 Jul; 27(7):718. PubMed ID: 16786513 [TBL] [Abstract][Full Text] [Related]